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BACKGROUND: The Barkey Plasmatherm (BP) can thaw plasma at 37C and 45C. No studies 
have assessed thawing times or haemostatic qualities of plasma thawed at 45C with BP. 
This study assessed FFP thawing times using BP at 37C and 45C and Thermogenesis 
Thermoline (TT) at 37C, and compared haemostatic quality of LG-Octaplas using BP at 37C 
and 45C with TT at 37C.
STUDY DESIGN AND METHODS: Thawing time of FFP (pairs or fours) was assessed using BP 
at 37C and 45C (not pre-warmed, and pre-warmed) and TT at 37C. Haemostasis was 
assessed in LG-Octaplas five minutes, 24 hours, 48 hours, and 120 hours post thaw using the 
three methods.
RESULTS: Thawing time for two units was 13.44’ using TT, the same as using BP at 37C 
(12.94’ not pre-warmed; 12.20’ pre-warmed) or 45C (12.38’ not pre-warmed), but longer 
than using BP pre-warmed to 45C (11.31’, p<0.001). Thawing time for four units was 13.41’ 
using TT, shorter than using BP at 37C (17.19’ not pre-warmed; 18.47’ pre-warmed; both 
p<0.001) or 45C (15.03’ not pre-warmed, p=0.012; 15.22’ pre-warmed, p=0.004). There 
was no reduction in haemostatic markers in LG-Octaplas using BP at 37C or 45C compared 
to TT.
CONCLUSION: BP is quicker than TT by two minutes when thawing two units of FFP if it is 
pre-warmed to 45C. BP is slower than TT by at least two minutes when thawing four units 
of FFP. There was no significant difference in the haemostatic qualities of plasma whether 
thawed at 37C or 45C. 
Keywords: Plasma thawing; haemostasis; water-bath
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In the last decade there has been an increase interest in transfusing fresh frozen plasma 
(FFP) and cryoprecipitate early for the treatment of massive haemorrhage, with clinical trials 
suggesting that this practice improves outcome for patients who are bleeding due to 
trauma.1,2 In order to improve the availability of plasma components for management of 
bleeding, many countries have now extended the shelf life of thawed FFP from 24 hours to 5 
days for thawed plasma and 14 days or more for liquid plasma.3-5 Although there have been 
no studies demostrating a clinical difference between freshly thawed plasma, extended 
shelf life thawed plasma or liquid plasma, and the PROPPR study1 used extended shelf life 
thawed plasma, in vitro data on thawed and liquid plasma has demonstrated that the 
haemostatic qualities of the components deteriorate over time.6 An optimal situation may 
be to have faster thawing methods that would allow for quick delivery of thawed plasma on 
demand, providing fresh components for patients. Fast thawing may also be desirable when 
stocks of thawed plasma are rapidly depleted, especially when multiple patients are being 
treated concurently, or in centres where plasma is not often required and pre-thawing may 
lead to increased wastage.
There are several methods available for thawing FFP including water-bath, microwave oven, 
and dry-heat based methods: current national guidance in the United Kingdom for thawing 
plasma recommends that the optimal temperature at which the components should be 
thawed is 37C (33C – 37C).4,7 
Barkey Plasmatherm (Barkey GmbH & Co. KG, Leopoldshöhe, Germany) is a water-based 
method that can thaw plasma at 37C and 45C temperatures. However, to our knowledge 
there have been no studies that have assessed the thawing time or the haemostatic 
qualities of plasma when thawed at 45C temperatures in comparison with other thawing 
methods. The aims of this study are to: a) assess the thawing times between Barkey 
Plasmatherm at 37C and 45C and Thermogenesis Thermoline (Helmer Scientific, Indiana, 
USA) at 37C, using variable volumes of single donor FFP; and b) compare the effect of 
thawing temperatures on the haemostatic qualities of LG-Octaplas (a pooled plasma 
component) using Barkey Plasmatherm (BP) at 37C and 45C and Thermogenesis 
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Thermoline (TT) at 37C. A pooled component rather than multiple units of FFP were used 
for the haemostatic assessment to reduce potential variation in clotting factors between 
units.  
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Fresh frozen plasma (FFP) was supplied by NHS Blood and Transplant (NHSBT) and was 
derived from UK whole blood donation (475mL ± 10%,) collected into 66.5mL CPD 
anticoagulant in top-and-top collection packs (FQE6283LB MacoPharma, Twickenham, UK) 
following NHSBT standard operation procedures.8 LG-Octaplas was supplied by Octapharma 
as part of routine delivery to hospital and was produced according to the manufacturer’s 
specification
Assessment of thawing times
For the assessment of thawing times, single expired FFP units in pairs or in fours were 
assessed eight times using: a) Barkey Plasmatherm (BP) at 37C, b) BP at 45C, and c) 
Thermogenesis Thermoline (TT) at 37C. The above experiment was repeated twice: 1) with 
the BP machine being switched on for <30 minutes, and 2) with the BP machine being 
switched on for at least four hours prior to the experiment. Assessment of thawing times 
was performed by two biomedical scientists using visual inspection for the absence of visible 
ice crystals, as this is the thawing end-point in most hospitals. 
Assessment of haemostatic capacity
LG-Octaplas is a pooled plasma product that is likely to show less variability in haemostatic 
qualities than FFP, so 24 LG-Octaplas units (eight thawed in the TT at 37C; eight thawed in 
the BP at 37C; eight thawed in the BP at 45C) were used for the assessment of 
haemostatic capacity stage of the experiment. A thawing time of 30 minutes at 37C (30C – 
37C) for LG-Octaplas is recommended by Octapharma Limited, and this timing was 
followed during the haemostatic assessment experiment for all three arms. After thawing, 
LG-Octaplas was stored at 2C – 4C and aliquots were taken for haemostatic testing at four 
different time-points: five minutes after removal from the thawing device (defined as time 
zero); 24 hours post thaw; 48 hours post thaw; and 120 hours post thaw – the latter timing 
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is the allowed extended shelf-life for thawed plasma in the UK.4 Samples were stored below 
-70C until testing was performed.7 
Assays performed were prothrombin time (PT); activated partial thromboplastin time 
(APTT); fibrinogen; factors II, V, VII, VIII and XI activity; free protein S antigen; protein S 
activity; protein C activity; C1-inhibitor activity; and thrombin generation (TG). All assays 
except for thrombin generation were performed on a Sysmex CS-2100 analyser. PT was 
measured using Siemens Dade Innovin, and factor II, V and VII activity were measured by 
one-stage assays using Innovin and Siemens factor deficient plasmas; APTT was measured 
using Siemens Dade Actin FS, and factor XI was measured by one-stage assay using Actin FS 
and Siemens factor deficient plasma; factor VIII assays were measured using Hyphen 
Biomed Biophen VIII chromogenic reagents; protein C activity was measured using Siemens 
Berichrom Protein C reagents; free protein S antigen was measured using Siemens 
INNOVANCE Free PS reagents; protein S activity was measured using Hyphen Biomed 
Hemoclot Protein S reagents; C1-inhibitor activity was measured using reagents from 
Siemens; fibrinogen was measured by the Clauss method using Siemens Thrombin. All these 
assays (except for PT and APTT) were calibrated using Siemens Standard Plasma and all 
reagents were supplied by Sysmex UK (Milton Keynes, UK).
Thrombin generation was performed using the Calibrated Automated Thrombogram 
Fluoroskan system (Thrombinoscope BV, Maastricht, The Netherlands) as described by 
Hemker et al9 in conjunction with the manufacturer’s PPP reagents, which gave reaction 
concentrations of 5pM tissue factor and 4µM phospholipid. The following parameters of the 
TG curve were measured: lag time; time to the peak (ttP); peak thrombin; and area under 
the curve, known also as the endogenous thrombin potential (ETP).
Statistical Analysis
Data have been summarized as medians with 95% confidence intervals. Coagulation factors 
were analysed using univariate statistical methods. Analysis of variance (ANOVA) was 
performed, comparing concentration of each factor across arms and over time. For thawing 
times, Fisher’s multiple comparisons test was used; for haemostatic assays Tukey’s multiple 
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comparisons test was used. For all tests a p value of below 0.05 indicated a statistically 
significant difference. 
Results 
There was no statistically significant difference in the volumes of FFP thawed in each arm of 
the experiment (Figure 1). 
Thawing times
Data are summarised in Figure 1.
For every increase in volume of 1mL there was a mean increase in thawing times for two 
units of 3.1 seconds at 37C (TT or BP) and 1.9 seconds at 45C; for four units the mean 
increase was 2.5 seconds (TT at 37C and BP at 45C) and 2.8 seconds (BP at 37C).
The thawing time for two units of FFP using the TT was 13.44 minutes (95% confidence 
interval (CI) 11.78-15.10). The thawing time for two units of FFP using the BP at 37C with 
pre-warming was 12.20 minutes (95% CI 11.77-12.63) compared to 12.94 minutes (95% CI 
11.09-14.79) without pre-warming.  The thawing time for two units of FFP using the BP at 
45C without pre-warming was 12.38 minutes (95% CI 11.70-13.05). None of these times 
were statistically significantly different from each other.
The thawing time for two units of FFP using the BP at 45C with pre-warming was 11.31 
minutes (95% CI 10.94-11.69); this was statistically significantly shorter than the thawing 
time using the TT by 2.13 minutes (p=0.030).
The thawing time for four units of FFP using the TT was 13.41 minutes (95% CI 12.81-14.01) 
which was not statistically significantly different from the thawing time for two units of FFP 
using the TT. When using the BP to thaw four units of FFP, the thawing time was statistically 
significantly longer than thawing in the TT whether using 37C without pre-warming (17.19 
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minutes, 95% CI 16.21-18.16, p<0.001) or with pre-warming (18.47 minutes, 95% CI 17.78-
19.16, p<0.001) or when using 45C without pre-warming (15.03 minutes, 95% CI 14.20-
15.86, p=0.012) or with pre-warming (15.22 minutes, 95% CI 14.44-16.00, p=0.004).
There was no statistically significant difference in thawing times using the BP whether the 
device was pre-warmed or not. 
Haemostatic assays 
Data are summarised in Figures 2 and 3.
For PT there was no statistically significant difference at time 0 between TT and BP at 37C 
or BP at 45C, and no statistically significant differences were seen within each thawing 
method at 24 hours, 48 hours or 120 hours. For all thawing methods, APTT showed a 
statistically significant increase over time but there was no statistically significant difference 
at all time points (time 0, 24 hours, 48 hours or 120 hours) between TT and BP at 37C or 
45C. Similarly, for fibrinogen there was no statistically significant difference at all time 
points between the three thawing methods.
Factor VIII showed a statistically significant decrease over time regardless of thawing 
method but there was no statistically significant difference between TT and BP at 45C at 
any time points, whereas factor VIII measured from the units thawed using the BP at 37C 
was statistically significantly higher at time zero (median 76.0iu/dL) than when using the TT 
(median 57.7iu/dL, p=0.009); there was no statistically significant difference in factor VIII 
between units thawed at TT and BP at 37C for any other time points. Factor V and protein S 
activity showed similar statistically significant decrease over time as for factor VIII but no 
statistically significant differences in results between TT and BP at 37C or 45C for any time 
points.
Endogenous thrombin potential was statistically significantly reduced over time following 
thawing, in line with the observed reduction of FVIII and FV. There was no statistically 
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significant difference at time 0 between TT and BP at 37C or 45C, and no statistically 
significant differences at 24 hours or 120 hours. Results for TT at 48 hours were statistically 
significantly lower than all other results: samples were run in the same batch as all samples 
for TT at 120 hours and a reason for this apparent anomaly could not be identified. Peak 
thrombin also statistically significantly reduced over time but there was no statistically 
significant difference at all time points between TT and BP at 37C or 45C. 
There were no statistically significant differences between temperatures or time points for 
factor II, factor VII, factor XI, protein C activity, free protein S antigen or C1-inhibitor. 
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The water bath method is the most commonly used method in the UK for thawing plasma, 
with the TT and BP being the most widely used devices. In this study we compared the two 
devices, and showed that with regards to thawing times TT was statistically significantly 
faster by at least two minutes when thawing four units of FFP, while BP at 45C was 
statistically significantly faster by at least two minutes than TT when thawing two units of 
FFP. The reason for this is likely to be due to the difference in the contact surfaces area 
between the plasma units and the water between the two methods. In the TT the surface 
area is larger allowing for quicker thawing times, whereas in BP plasma units are placed 
close to each other thus, reducing the surface area with warm water and slowing down the 
thawing times. 
In addition to thawing times, hospital transfusion laboratory who are considering the 
purchase of plasma thawing devices should also consider other factors, such as size, and 
maintenance of the device. For the two methods that we compared in this study, the TT is 
bigger in size than BP, allowing for up to ten units of plasmas being thawed at once – this 
can be a major advantage when dealing with mass casualties, however it will require more 
laboratory space to house. The BP can thaw a maximum of eight units (something that was 
not tested in this study), but four of these have to be placed below the cushions and need to 
be moved once first four units have been thawed and removed. Further, the cleaning and 
maintenance of TT is more demanding than BP: the TT requires the water to be changed 
regularly by laboratory staff, whereas the BP only requires the water to be replaced 
completely on an annual basis during the routine preventative maintenance; and in the TT 
spillages can enter the water, facilitating the need for complete replacement of the tank 
water, whereas the BP does not allow the water to come into contact with the product, as it 
uses a sealed tank method. Water is pumped into cushions and circulated. Should either the 
plasma bag or cushion rupture this is contained and easily cleaned.
In the UK, it is believed that temperatures close to 37C may be optimal, and that thawing 
plasma at higher temperatures might affect the viability of plasma proteins.4,10 The current 
UK recommendations state that plasma should be thawed at 33C – 37C.4 However, to our 
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knowledge, there have been no studies that have compared BP at 45C with 37C thawing 
using other methods. The clinical need to have plasma available quickly for the management 
of major bleeding may have led to hospitals using a higher-than-recommended thawing 
temperature for plasma. While the extension of the shelf-life of thawed plasma has 
improved the availability of FFP in emergency situations, anecdotally this is still associated 
with some degree of wastage, particularly in hospitals that do not use a lot of plasma on a 
daily basis, and speeding up the thawing process for FFP could achieve a balance between 
reduced wastage and improved availability. In this study we observed that heat labile 
clotting factor levels and endogenous thrombin potential were statistically significantly 
reduced over time after thawing with both BP and TT devices: these findings are consistent 
with other studies4,6 but the clinical impact of these reductions is not known. In this study, 
we did not see any statistically significant differences in any of the haemostatic markers of 
LG-Octaplas thawed at 45C using BP compared to thawing at 37C with BP or TT. Our 
results should give reassurance to clinicians and blood transfusion laboratories who are 
considering introducing a 45C thawing temperature with the BP device, in that we found 
no evidence that this higher temperature of thawing for 30 minutes impairs the quality of 
plasma, but it should be noted that a limitation of our study is that the temperature of 
plasma after 30 minutes of thawing was not measured. There did not appear to be an 
advantage to leaving the BP switched on, suggesting that it can be switched on at the same 
time as thawing FFP is initiated. Further studies are required to validate our results. 
In conclusion, compared to the TT, when thawing two units of FFP, the BP at 37C is not 
statistically significantly different, but at 45C is statistically significantly quicker by more 
than two minutes. When thawing four units of FFP the BP is statistically significantly slower 
than the TT by two minutes. These results were not statistically different whether the BP 
was pre-warmed or not. There was no statistically significant difference in the haemostatic 
qualities of plasma between 37oC and 45oC thawing temperatures. 
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Figure 1: Comparison of FFP volumes and thawing times for 2 and 4 units thawed 
together (n=8). TT: Thermogenesis Thermoline; BP: Barkey Plasmatherm; *: 
0.01<p<0.05; **: 0.001<p0.01; ***: 0.0001<p0.001; ****: p<0.0001. Box plots 
show median, 5th and 95th percentile and minimum and maximum values.
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Figure 2: Comparison of clotting assays and thrombin generation in Octaplas following 
thawing by different methods. TT: Thermogenesis Thermoline; BP: Barkey 
Plasmtherm; PT: prothrombin time; APTT: activated partial thromboplastin time; 
ETP: endogenous thrombin potential. *: 0.01<p<0.05; **: 0.001<p0.01; ***: 
0.0001<p0.001; ****: p<0.0001. Box plots show median, 5th and 95th percentile 
and minimum and maximum values.
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Figure 3: Comparison of haemostasis assays in LG-Octaplas following thawing by different 
methods. TT: Thermogenesis Thermoline; BP: Barkey Plasmatherm. Box plots 
show median, 5th and 95th percentile and minimum and maximum values.
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Figure 1: Comparison of FFP volumes and thawing times for 2 and 4 units. TT: 
Thermogenesis Thermoline; BP: Barkey Plasmatherm; *: 0.01<p<0.05; **: 0.001<p0.01; 
***: 0.0001<p0.001; ****: p<0.0001. Box plots show median, 5th and 95th percentile and 
minimum and maximum values.
Figure 2: Comparison of clotting assays and thrombin generation in Octaplas following 
thawing by different methods. TT: Thermogenesis Thermoline; BP: Barkey Plasmtherm; PT: 
prothrombin time; APTT: activated partial thromboplastin time; ETP: endogenous thrombin 
potential. *: 0.01<p<0.05; **: 0.001<p0.01; ***: 0.0001<p0.001; ****: p<0.0001. Box 
plots show median, 5th and 95th percentile and minimum and maximum values.
Figure 3: Comparison of haemostasis assays in LG-Octaplas following thawing by different 
methods. TT: Thermogenesis Thermoline; BP: Barkey Plasmatherm. Box plots show median, 
5th and 95th percentile and minimum and maximum values.
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